ixlayer

ixlayer is the only end-to-end, direct-to-patient platform built for biopharma and optimized for patient choice.

[ixlayer @ixlayer_]

Honored to share that @ixlayer_ and @sanofi have been named a @PM360online ELITE Marketing, Trade, and Commercial Innovation Team for our work on Screening Central—a bold collaboration that’s redefining what direct-to-consumer programs can look like. https://t.co/l1nWw7JTA6

[ixlayer @ixlayer_]

https://t.co/Ho7IhInaAu

[ixlayer @ixlayer_]

Patients are voting with their clicks— 86 % have used a digital health tool in the past year, but their top frustration is juggling too many apps that don’t talk to one another .
https://t.co/AeNQaIOcOO

[L.A. Care Health Plan @LACareHealth]

L.A. Care is a finalist in the @FierceHealth #DEIAwards for Outstanding DEI Initiative in Patient Care with our partner @ixlayer_! Our At-Home Diagnostic Program nearly doubled our preventive colorectal cancer, diabetes, and kidney disease screenings rates.📦🩺

https://t.co/Up6oVWnnUI

[ixlayer @ixlayer_]

Almost every pharma marketer and commercialization leader is asking about direct-to-patient platform opportunities. But what do patients want? Thanks to @FiercePharma and the reporting by @andreapark on the ixlayer #ixInsight2025 Study with @Ipsos.
https://t.co/01LDWsYiaK

[ixlayer @ixlayer_]

We are excited to be named to the @DigitalHealthNY 100, joining the ranks of past winners @capsule_health , @mavenclinic , @OscarHealth, @ro , @swordhealth , @Talkiatry , @talkspace and @Zocdoc. Read more in today's press release:

https://t.co/vNkxwBgn1i

[ixlayer @ixlayer_]

Proud to powering Screening Central,@SanofiUS first #telehealth-enabled, user-initiated #T1D autoantibody screening platform, now available across the U.S.
Expanding access to early screening means more #proactivehealth and better #healthoutcomes.

https://t.co/ki5sSMhBK8

[Pear VC @pearvc]

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients.

Congratulations! #HLTHUSA

[Pejman Nozad @pejmannozad]

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients.
Congratulations! #HLTHUSA

[ixlayer @ixlayer_]

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth
https://t.co/YlqlLqAeYY

[ixlayer @ixlayer_]

We’re pleased to announce the launch of ixEngage, our direct-to-patient solution for biopharma that builds on our groundbreaking digital platform that has powered 1,110+ nationwide programs and over 4 million patient care journeys:

https://t.co/HELQG0GLuM

[ixlayer @ixlayer_]

Attending #DPE24? Don’t miss out on our panel discussion, “Leveraging Technology to Improve the Patient Experience and Drive Better Outcomes” featuring insights marketers from @sanofi , @AstraZeneca, @CSLBehring. #DigitalPharmaEast #FiercePharma #DigitalPharma #PharmaMarketing

[ixlayer @ixlayer_]

ixlayer direct-to-patient platform allows biopharma organizations to quickly launch an optimized patient Cx with transparency and control. Our configurable platform enables us to build distinct programs for multiple therapeutic areas within biopharma ecosystem.

[ixlayer @ixlayer_]

NEW IXLAYER PHYSICIAN SURVEY REVEALS OVERWHELMING SUPPORT FOR AT-HOME DIAGNOSTIC TESTING: https://t.co/YFlQnO6lQc

[ixlayer @ixlayer_]

HCPs show cautious support for at-home diagnostic testing https://t.co/sT0FcOlekw

[ixlayer @ixlayer_]

Doctors support growth of at-home testing, survey finds, opening new avenues for biopharma patient outreach https://t.co/2C8NK8WE6t

[Medical Product Outsourcing @MPOmagazine]

New @ixlayer_ survey shows a large support of at-home diagnostic testing: https://t.co/aoKc4ianuy

[Fierce Pharma Marketing @FiercePharmaMkt]

🎉We are thrilled to announce @ixlayer_ as a proud partner for #DPEAST 2024! Get tickets to Digital Pharma East here: https://t.co/uFPsecr8Jo

#DigitalPharma #DigPharm #pharmamarketing #digitalmarketing #marketing #innovationinhealthcare

[ixlayer @ixlayer_]

We’re pleased to announce the expansion to our Clinical Advisory Board with the addition of Kevin Ban, MD, Chief Medical Officer with Walgreens. Dr Ban brings over 25 years of clinical and administrative experience. Read more: https://t.co/9S0Vj9KIQy

[ixlayer @ixlayer_]

We’re excited to announce the launch of our new data visualization solution that empowers healthcare organizations to harness real-time data for actionable insights to improve outcomes across the healthcare ecosystem. Read more: https://t.co/q8pIInFZya